Kingsley Stuart A 4

What Happened
Stuart A. Kingsley, a director of Indivior Pharmaceuticals (INDV), made an open-market purchase of 940 shares on 2026-03-06 at $31.86 per share, for a total of approximately $29,953. This was a straightforward purchase (transaction code P); purchases by insiders are often more informative to investors than routine sales, though the filing does not state Kingsley’s motivation.

Key Details

• Transaction date and price: 2026-03-06 — 940 shares at $31.86 each.
• Total value: ~$29,953.
• Transaction type: Open market purchase (Form 4 code P).
• Shares owned after transaction: Not specified in the filing.
• Filing date: Form filed 2026-03-11 (the Form 4 was filed one business day late; the transaction occurred 2026-03-06 and the filing was due within two business days).
• Footnotes/plans: No 10b5-1 plan, tax withholding, or other footnotes are disclosed in the reported transaction.

Context
This was a direct open-market buy, not an option exercise, gift, or award. The late filing reduces timeliness of the disclosure but does not change the facts of the purchase. As always, insider purchases signal that the insider chose to invest personal capital, but they do not guarantee future stock performance.